7,243 results match your criteria: "Blood Dyscrasias and Stroke"
Neurology
January 2025
From the Department of Neurology (M.A.A., W.R., A.K.S., M.J.D.), Department of Radiology and Radiological Sciences (D.M., L.T.D., L.C.J.), Division of Pediatric Neurology, Department of Pediatrics (S.M.D., L.L.M., L.C.J.), Division of Hematology and Oncology, Department of Medicine (A.A.K., M.R.D.), and Department of Psychiatry and Behavioral Sciences (M.J.D.), Vanderbilt University Medical Center, Nashville; Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease (A.A.K., M.R.D.), Nashville; and Department of Electrical and Computer Engineering (M.J.D.), Vanderbilt University, Nashville, TN.
Background And Objectives: Sickle cell disease (SCD) is a hemoglobinopathy resulting in hemoglobin-S production, hemolytic anemia, and elevated stroke risk. Treatments include oral hydroxyurea, blood transfusions, and hematopoietic stem cell transplantation (HSCT). Our objective was to evaluate the neurologic relevance of these therapies by characterizing how treatment-induced changes in hemoglobin (Hb) affect brain health biomarkers.
View Article and Find Full Text PDFBlood Rev
December 2024
Centre for Haematology, Imperial College of Science, Technology and Medicine, London, UK; Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
Wiad Lek
December 2024
UZHHOROD NATIONAL UNIVERSITY, UZHHOROD, UKRAINE.
Objective: Aim: We aimed to assess the prevalence of ID in patients HFpEF and its relation to functional capacity and quality of life.
Patients And Methods: Materials and Methods: We included in the analysis 121 consecutive outpatients newly diagnosed of HFpEF and tested with iron-related parameters. Patients were subdivided in two groups according to the presence of ID (n = 76, mean age 65.
Hematology Am Soc Hematol Educ Program
December 2024
Department of Paediatrics, Government Medical College, Nagpur, Maharashtra, India.
India, the most populous nation in the world, also has a high frequency of the sickle hemoglobin (HbS) allele globally. The Arab Indian HbS haplotype in India is characterized by a relatively high percentage of fetal Hb, with widely varying frequencies of α-thalassemia. Hence, sickle cell disease (SCD) in India was perceived to be mild.
View Article and Find Full Text PDFHematology Am Soc Hematol Educ Program
December 2024
Department of Haematology, University of Benin Teaching Hospital, Benin City, Nigeria.
Nat Cardiovasc Res
December 2024
Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Cerebral cavernous malformation (CCM) is a neurovascular disease with symptoms such as strokes, hemorrhages and neurological deficits. With surgery being the only treatment strategy, understanding the molecular mechanisms of CCM is crucial in finding alternative therapeutic options for CCM. Neutrophil extracellular traps (NETs) were recently reported in CCM, and NETs were shown to have positive or negative effects in different disease contexts.
View Article and Find Full Text PDFSemin Pediatr Neurol
December 2024
Human Biochemical Genetics Section, Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address:
BMJ Open
November 2024
Subaquatic and Hyperbaric Medicine Unit, Emergency Service, Acute Medicine Department, Geneva University Hospitals, Geneva, Switzerland.
J Crit Care
February 2025
Department of Emergency and Critical Care Medicine, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan; Department of Clinical Engineering, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. Electronic address:
Medicina (Kaunas)
November 2024
Department of Cardiology, School of Medicine, Ondokuz Mayıs University, 55200 Samsun, Turkey.
Georgian Med News
September 2024
Objective: To investigate the spectrum of neurological disorders in children with juvenile localized scleroderma (JLS) on face and JLS without plaques on face and head.
Materials And Methods: 156 children with JLS were examined were with a neurological examination MRI, EEG, genetic thrombophilia markers detection.
Results: Neurological disorders (ND) were found in 56 from 114 (49%) of the patients with scleroderma of head and face (LSH)(group1) and in 30% (13 from 42) with JLS without plaques on face (Group 2).
Nutr Metab Cardiovasc Dis
January 2025
National Key Laboratory for Innovation and Transformation of Luobing Theory, The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences, Department of Cardiology, Qilu Hospital of Shandong University, Jinan, China; Department of Cardiology, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, 758 Hefei Road, Qingdao, Shandong, 266035, China. Electronic address:
Background And Aims: Iron deficiency (ID) leads to a significant global health burden, but research on the impact of ID on the prognosis of stroke patients is rare. We aim to investigate the impact of ID on the all-cause mortality of both the stroke and non-stroke individuals.
Methods And Results: This retrospective cohort study used data from the National Health and Nutrition Examination Survey (NHANES) conducted from 1999 to 2002.
Microsurgery
November 2024
Division of Plastic and Reconstructive Surgery, Keck School of Medicine, Los Angeles, California, USA.
Purpose: Although blood loss in microsurgical reconstruction is rarely large enough to be life-threatening, preoperative anemia can be a particular issue in terms of postoperative morbidity, impaired wound healing, and compromised tissue viability. We seek to review the effect of preoperative hemoglobin (Hgb) levels on perioperative blood transfusion (PBT) requirements and complications to guide management of patients with preexisting anemia undergoing reconstruction.
Methods: PubMed, Embase, and Scopus were queried for relevant articles.
Neurology
December 2024
From the Department of Neurology (Y.W., S.F., K.G., M.E.F., J.B.L., Y.C., J.-M.L.), Mallinckrodt Institute of Radiology (M.R., K.G., M.E.F., C.Y., J.-M.L., H.A.), and Division of Pediatrics (K.G., A.E.M., M.L.H.), Center for Biostatistics and Data Science (K.S.-M.), Washington University School of Medicine; Washington University in St. Louis (R.A.C.); and Division of Hematology/Oncology (A.A.K., A.L.F.), Department of Medicine, Washington University School of Medicine, St. Louis, MO.
Background And Objectives: Large vessel vasculopathy (LVV), or moyamoya syndrome, increases the risk of stroke in patients with sickle cell disease (SCD), yet effective treatments are lacking. In atherosclerotic carotid disease, previous studies demonstrated elevated oxygen extraction fraction (OEF) as a predictor of ipsilateral stroke. In a SCD cohort, we examined hemispheric hemodynamic and oxygen metabolic dysfunction as tissue-based biomarkers of cerebral ischemic risk in patients with LVV.
View Article and Find Full Text PDFClin Appl Thromb Hemost
November 2024
Faculty of Medecine of Monastir Tunisia, University of Monastir, Monastir, Tunisia.
Background: Emicizumab, a bispecific factor VIII mimetic antibody, was approved in 2018 for bleeding prophylaxis in congenital hemophilia A with or without inhibitors. Since then, several case reports and case series have described the off-label use of emicizumab in acquired hemophilia A (AHA), and data from two clinical trials were recently published (AGEHA, GTH-AHA-EMI).
Objectives: To describe the reported data on the outcomes of emicizumab, highlighting its benefit/risk profile in treatment.
West Afr J Med
November 2024
Department of Paediatrics, Edward Francis Small Teaching Hospital, Banjul, The Gambia. E-mail:
Introduction/background: Children with sickle cell anaemia (SCA) experience recurrent vaso-occlusive crises and complications with possible impact on their health-related quality of life (HRQoL).
Objectives: This study determined HRQoL of 130 children aged 5-15 years with SCA and compared it to age- and sex-matched apparently healthy haemoglobin AA children in The Gambia. It also determined the impact of SCD severity, and sociodemographic and clinical data on HRQoL.
Nature
December 2024
Department of Tissue Morphogenesis, Max Planck Institute for Molecular Biomedicine, Münster, Germany.
J Am Heart Assoc
November 2024
The Zena and Michael A. Wiener Cardiovascular Institute, The Mount Sinai Fuster Hospital Icahn School of Medicine at Mount Sinai New York NY.
Transfusion
December 2024
Division of Hematology, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Arq Bras Cardiol
October 2024
Centro de Pesquisa Clínica e Epidemiológica - Universidade de São Paulo, São Paulo, SP - Brasil.
Cureus
September 2024
Neurology, Antalya Training and Research Hospital, Antalya, TUR.
Introduction Migraine is one of the most common neurological diseases. Comorbidities, especially stroke, may be observed. White matter hyperintensities are common in migraine patients.
View Article and Find Full Text PDFBMC Pediatr
October 2024
Department of Pediatrics, Mubarak Al-Kabeer Hospital, Ministry of Health, Kuwait City, Kuwait.
Introduction: Stroke is one of the most devastating complications of sickle cell disease (SCD). Transcranial Doppler Imaging (TCDI) is the least invasive screening method to predict patients at risk for developing stroke in the disease. After a 10-year follow-up, we longitudinally assessed the TCDI in children with SCD without neurological symptoms.
View Article and Find Full Text PDFBr J Haematol
October 2024
Section of Internal and Cardiovascular Medicine, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
No risk factors have been identified for vaccine-induced immune thrombotic thrombocytopenia (VITT) so far. The aim of this study was to identify human leucocyte antigen (HLA) alleles potentially associated with VITT susceptibility. Specific HLA class II alleles were detected with significantly higher frequency in VITT patients compared with Italian controls: DPB1*17:01, DQA1*05:01, and DRB1*11:04.
View Article and Find Full Text PDFBackground: Tranexamic acid, given within 3 h of birth, reduces bleeding deaths in women with postpartum haemorrhage. We examined whether giving tranexamic acid shortly after birth can prevent postpartum haemorrhage in women with moderate or severe anaemia.
Methods: This international, randomised, double-blind, placebo-controlled trial was done in 34 hospitals across four countries (Nigeria, Pakistan, Tanzania, and Zambia).